Quantifying Intracellular Platinum Accumulation Using Inductively Coupled Mass Spectrometry.

Area of Science:

• Analytical Chemistry
• Cancer Therapeutics
• Molecular Biology

Background:

• Platinum-based drugs like cisplatin are widely used cancer treatments.
• Challenges include cisplatin resistance and severe side effects due to general cytotoxicity.
• Monitoring intracellular platinum levels is crucial for optimizing dosage and efficacy.

Purpose of the Study:

• To describe a protocol for quantifying cisplatin accumulation in cellular fractions using ICP-MS.
• To provide a reliable method for measuring subcellular platinum concentrations.
• To support research aimed at improving platinum-based chemotherapy.

Main Methods:

• Cell culture and treatment with cisplatin.
• Isolation of RNA-free DNA and cellular fractions.
• Sample digestion followed by ICP-MS analysis and data interpretation.

Main Results:

• A detailed protocol for quantifying cisplatin in chromatin and total cell lysate was established.
• The method is sensitive and adaptable to various cell lines and tissues.
• Successful measurement of cisplatin accumulation was demonstrated.

Conclusions:

• The developed ICP-MS protocol enables accurate measurement of subcellular platinum drug concentrations.
• This method can help researchers understand cisplatin resistance mechanisms and side effects.
• It serves as a valuable resource for optimizing platinum-based cancer therapies.